Movellus has unveiled what it claims to be the industry's first on-chip power delivery network (PDN) analyzer, designed to enhance the performance and efficiency of system-on-chips (SoCs). The newly introduced Aeonic Insight PDN IQ aims to provide unprecedented transistor-level PDN visibility, addressing the critical challenge of power integrity across the entire lifecycle of semiconductors, from characterization to in-field monitoring. As SoCs become more complex, especially in the realm of AI accelerators and large devices, Movellus's innovation promises to optimize power-performance characteristics by offering direct and continuous PDN monitoring and analytics. This capability could allow design teams to refine voltage-frequency points and improve system reliability, which is increasingly vital as demand for high-performing AI technologies surges.
In other trading, Rockchip Electronics (SHSE:603893) was a standout up 10% and finishing the session at CN¥170.47. At the same time, QUALCOMM (NasdaqGS:QCOM) trailed, down 8.9% to finish the session at $135.21. On Tuesday, the company reported a significant increase in quarterly revenue and net income compared to the previous year.
Best AI Chip Stocks
- NVIDIA (NasdaqGS:NVDA) finished trading at $111.61 up 2.5%. Last week, NVIDIA urged shareholders to vote against several shareholder proposals at the upcoming annual meeting.
- Intel (NasdaqGS:INTC) settled at $19.98 down 0.6%. On Wednesday, Intel's Chief Commercial Officer Christoph Schell announced his resignation to become CEO of Kuka.
- Advanced Micro Devices (NasdaqGS:AMD) finished trading at $96.65 down 0.7%. On Tuesday, AMD presented at the OCP EMEA Summit 2025 in Dublin, highlighting their advancements with a speech by Raj Kapoor, Fellow – Chief Firmware Architect.
Next Steps
- Take a closer look at our AI Chip Stocks list of 48 companies, such as Will Semiconductor, Disco and KLA, by clicking here.
- Looking For Alternative Opportunities? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
Valuation is complex, but we're here to simplify it.
Discover if NVIDIA might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com